BlackRock, Inc. 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:32 pm Purchase | 2024-11-30 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 40,451,057 10.400% | 7,599,584 (+23.13%) | Filing |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 32,851,473 8.500% | -684,207 (-2.04%) | Filing |
| 2023-02-10 4:22 pm Sale | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,535,680 8.700% | -347,000 (-1.02%) | Filing |
| 2023-01-27 2:36 pm Unchanged | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,882,680 8.700% | 0 (Unchanged) | Filing |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,882,680 8.800% | 1,368,864 (+4.21%) | Filing |
| 2022-02-08 5:12 pm Purchase | 2021-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 32,513,816 8.400% | 4,480,524 (+15.98%) | Filing |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 28,033,292 7.300% | 6,040,672 (+27.47%) | Filing |